145 related articles for article (PubMed ID: 27725923)
1. Use of Protoporphyrin Fluorescence to Determine Clinical Target Volume for Non-melanotic Skin Cancers Treated with Primary Radiotherapy.
Casey S; Best L; Vujovic O; Jordan K; Fisher B; Carey D; Bourdeau D; Yu E
Cureus; 2016 Sep; 8(9):e767. PubMed ID: 27725923
[TBL] [Abstract][Full Text] [Related]
2. An experimental investigation of a novel iron chelating protoporphyrin IX prodrug for the enhancement of photodynamic therapy.
Anayo L; Magnussen A; Perry A; Wood M; Curnow A
Lasers Surg Med; 2018 Jul; 50(5):552-565. PubMed ID: 29603761
[TBL] [Abstract][Full Text] [Related]
3. Development of a handheld fluorescence imaging device to investigate the characteristics of protoporphyrin IX fluorescence in healthy and diseased skin.
Kulyk O; Ibbotson SH; Moseley H; Valentine RM; Samuel ID
Photodiagnosis Photodyn Ther; 2015 Dec; 12(4):630-9. PubMed ID: 26467274
[TBL] [Abstract][Full Text] [Related]
4. Thermo-Mechanical Fractional Injury Enhances Skin Surface- and Epidermis- Protoporphyrin IX Fluorescence: Comparison of 5-Aminolevulinic Acid in Cream and Gel Vehicles.
Foged C; Haedersdal M; Bik L; Dierickx C; Phillipsen PA; Togsverd-Bo K
Lasers Surg Med; 2021 Jul; 53(5):622-629. PubMed ID: 33001491
[TBL] [Abstract][Full Text] [Related]
5. Microscopic localisation of protoporphyrin IX in normal mouse skin after topical application of 5-aminolevulinic acid or methyl 5-aminolevulinate.
de Bruijn HS; Meijers C; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ
J Photochem Photobiol B; 2008 Aug; 92(2):91-7. PubMed ID: 18571933
[TBL] [Abstract][Full Text] [Related]
6. Regression Analysis of Protoporphyrin IX Measurements Obtained During Dermatological Photodynamic Therapy.
Tyrrell J; Paterson C; Curnow A
Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30634715
[TBL] [Abstract][Full Text] [Related]
7. Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolevulinic acid: implications for photodynamic treatment.
Martin A; Tope WD; Grevelink JM; Starr JC; Fewkes JL; Flotte TJ; Deutsch TF; Anderson RR
Arch Dermatol Res; 1995; 287(7):665-74. PubMed ID: 8534131
[TBL] [Abstract][Full Text] [Related]
8. The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy.
Choudry K; Brooke RC; Farrar W; Rhodes LE
Br J Dermatol; 2003 Jul; 149(1):124-30. PubMed ID: 12890205
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence induction of protoporphyrin IX by a new 5-aminolevulinic acid nanoemulsion used for photodynamic therapy in a full-thickness ex vivo skin model.
Maisch T; Santarelli F; Schreml S; Babilas P; Szeimies RM
Exp Dermatol; 2010 Aug; 19(8):e302-5. PubMed ID: 19845760
[TBL] [Abstract][Full Text] [Related]
10. The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome.
Tyrrell JS; Campbell SM; Curnow A
Lasers Surg Med; 2010 Sep; 42(7):613-9. PubMed ID: 20806386
[TBL] [Abstract][Full Text] [Related]
11. δ-Aminolevulinic acid and its methyl ester induce the formation of Protoporphyrin IX in cultured sensory neurones.
Novak B; Schulten R; Lübbert H
Naunyn Schmiedebergs Arch Pharmacol; 2011 Dec; 384(6):583-602. PubMed ID: 21947250
[TBL] [Abstract][Full Text] [Related]
12. [Fluorescence diagnostics of skin tumors using 5-aminolevulinic acid and its methyl ester].
Liutkeviciūte-Navickiene J; Mordas A; Simkute S; Bloznelyte-Plesniene L
Medicina (Kaunas); 2009; 45(12):937-42. PubMed ID: 20173396
[TBL] [Abstract][Full Text] [Related]
13. A time course investigation of the fluorescence induced by topical application of 5-aminolevulinic acid and methyl aminolevulinate on normal human skin.
Lesar A; Ferguson J; Moseley H
Photodermatol Photoimmunol Photomed; 2009 Aug; 25(4):191-5. PubMed ID: 19614897
[TBL] [Abstract][Full Text] [Related]
14. Protoporphyrin IX fluorescence induced in basal cell carcinoma by oral delta-aminolevulinic acid.
Tope WD; Ross EV; Kollias N; Martin A; Gillies R; Anderson RR
Photochem Photobiol; 1998 Feb; 67(2):249-55. PubMed ID: 9487802
[TBL] [Abstract][Full Text] [Related]
15. The effects of protoporphyrin IX-induced photodynamic therapy with and without iron chelation on human squamous carcinoma cells cultured under normoxic, hypoxic and hyperoxic conditions.
Blake E; Allen J; Curnow A
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):575-82. PubMed ID: 24284114
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Physical Pretreatment Regimens to Enhance Protoporphyrin IX Uptake in Photodynamic Therapy: A Randomized Clinical Trial.
Bay C; Lerche CM; Ferrick B; Philipsen PA; Togsverd-Bo K; Haedersdal M
JAMA Dermatol; 2017 Apr; 153(4):270-278. PubMed ID: 28146245
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence staining of oral cancer using a topical application of 5-aminolevulinic acid: fluorescence microscopic studies.
Leunig A; Mehlmann M; Betz C; Stepp H; Arbogast S; Grevers G; Baumgartner R
J Photochem Photobiol B; 2001 Apr; 60(1):44-9. PubMed ID: 11386680
[TBL] [Abstract][Full Text] [Related]
18. Lack of effect of selected sunscreens applied on ex vivo human skin for 5-methyl-aminolevulinic acid penetration and protoporphyrin IX photoactivation.
Osman-Ponchet H; Sevin K; Gaborit A; Kouidhi M; Hanaizi J; Comby P; Ruty B; Bouvier G
Photodiagnosis Photodyn Ther; 2017 Mar; 17():75-81. PubMed ID: 27903435
[TBL] [Abstract][Full Text] [Related]
19. Recommendations for CTV margins in radiotherapy planning for non melanoma skin cancer.
Khan L; Choo R; Breen D; Assaad D; Fialkov J; Antonyshyn O; McKenzie D; Woo T; Zhang L; Barnes E
Radiother Oncol; 2012 Aug; 104(2):263-6. PubMed ID: 22857860
[TBL] [Abstract][Full Text] [Related]
20. The time-dependent accumulation of protoporphyrin IX fluorescence in nodular basal cell carcinoma following application of methyl aminolevulinate with an oxygen pressure injection device.
Blake E; Campbell S; Allen J; Mathew J; Helliwell P; Curnow A
J Photochem Photobiol B; 2012 Dec; 117():97-103. PubMed ID: 23092624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
